We are live on ! Find out more
LIVN icon

LivaNova

180 hedge funds and large institutions have $2.06B invested in LivaNova in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 44 increasing their positions, 88 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.91% less ownership

Funds ownership: 94.92%94.01% (-0.91%)

2% less funds holding

Funds holding: 183180 (-3)

8% less capital invested

Capital invested by funds: $2.24B → $2.06B (-$174M)

11% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 28

50% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 88

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $303K

Holders
180
Holders Change
-3
Holders Change %
-1.64%
% of All Funds
3.63%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
25
Increased
44
Reduced
88
Closed
28
Calls
Puts
$303K
Net Calls
-$303K
Net Calls Change
-$5.79M

LIVN Hedge Fund Activity: Q3 2020 in Review

180 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in LivaNova (LIVN) for Q3 2020, worth a combined $2.06B — down 7.8% from $2.24B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of LIVN and 25 opened new positions — a net loss of 3 holders — while 88 trimmed existing stakes and 44 added.

The largest buyer was Barrow, Hanley, Mewhinney & Strauss, adding an estimated $78M. The largest seller was HealthCor Management, exiting entirely with an estimated $69.6M sold.

  • 180 institutional investors held LivaNova (LIVN) as of Q3 2020, down from 183 in Q2 2020.
  • Funds reported $2.06B of LivaNova stock for Q3 2020, down 7.8% quarter-over-quarter.
  • 25 funds opened new LivaNova positions in Q3 2020 and 28 closed out, a net change of -3 holders.
  • The largest LivaNova buyer in Q3 2020 was Barrow, Hanley, Mewhinney & Strauss, an estimated $78M added.
  • The largest LivaNova seller in Q3 2020 was HealthCor Management, an estimated $69.6M sold.

Based on aggregated 13F filings for Q3 2020.